High Vista Strategies LLC Pharvaris N.V. Transaction History
High Vista Strategies LLC
- $241 Million
- Q2 2025
A detailed history of High Vista Strategies LLC transactions in Pharvaris N.V. stock. As of the latest transaction made, High Vista Strategies LLC holds 23,739 shares of PHVS stock, worth $527,955. This represents 0.17% of its overall portfolio holdings.
Number of Shares
23,739
Previous 22,768
4.26%
Holding current value
$527,955
Previous $357,000
16.81%
% of portfolio
0.17%
Previous 0.15%
Shares
3 transactions
Others Institutions Holding PHVS
# of Institutions
58Shares Held
39.2MCall Options Held
0Put Options Held
0-
General Atlantic LLC New York, NY7.53MShares$167 Million4.61% of portfolio
-
Foresite Capital Management Iv, LLC Larkspur, CA4.41MShares$98.1 Million85.48% of portfolio
-
Ven Bio Partners LLC San Francisco, CA4.29MShares$95.4 Million79.45% of portfolio
-
Viking Global Investors LP3.65MShares$81.2 Million0.2% of portfolio
-
Bain Capital Life Sciences Investors, LLC Boston, MA3.3MShares$73.5 Million17.44% of portfolio
About Pharvaris N.V.
- Ticker PHVS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 33,766,000
- Market Cap $751M
- Description
- Pharvaris N.V., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapies for rare diseases. The company develops PHA121, a small molecule bradykinin B2-receptor antagonist that is in Phase II clinical trial for the treatment of hereditary angioedema (HAE). It also develops PHVS416, an on-demand, r...